Pediapharm Inc. (CVE:PDP – Get Free Report) shares traded up 1.7% on Thursday . The company traded as high as C$0.31 and last traded at C$0.30. 26,000 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The business’s 50-day simple moving average is C$0.30 and its two-hundred day simple moving average is C$0.30. The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 186.87. The firm has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Further Reading
- Five stocks we like better than Pediapharm
- 5 Top Rated Dividend Stocks to Consider
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Why Invest in High-Yield Dividend Stocks?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Insider Trading – What You Need to Know
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
